SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy

In the areas of chemotherapy, targeted therapy and immunotherapy, several interesting and clinically relevant data were presented at the 2017 San Antonio Breast Cancer Symposium (SABCS). This short review focuses on dose-dense and/or sequential administration of adjuvant chemotherapy, provides an up...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartsch, Rupert, Bergen, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2018
Materias:
Short Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132803/
https://www.ncbi.nlm.nih.gov/pubmed/30220927
http://dx.doi.org/10.1007/s12254-018-0430-0
Descripción
Sumario:In the areas of chemotherapy, targeted therapy and immunotherapy, several interesting and clinically relevant data were presented at the 2017 San Antonio Breast Cancer Symposium (SABCS). This short review focuses on dose-dense and/or sequential administration of adjuvant chemotherapy, provides an update on targeted therapies for HER2-positive and triple-negative breast cancer and summarizes new results in the field of immunotherapy.

Ejemplares similares